• 1
    Butler, T. (1983) Plague and Other Yersinia Infections, pp. 1–220. Plenum, New York.
  • 2
    Butler, T. (1979) Plague and tularemia. Pediatr. Clin. North. Am. 26, 355366.
  • 3
    Reed, W.P., Palmer, D.L., Williams, R.C. Jr. and Kisch, A.L (1970) Bubonic plague in the Southwestern United States. A review of recent experience. Med. Baltimore 49, 465486.
  • 4
    Cohen, R.J. and Stockard, J.L. (1967) Pneumonic plague in an untreated plague-vaccinated individual. J. Am. Med. Assoc. 202, 217218.
  • 5
    Butler, T. (1995) Yersinia species (including plague). In: Principles and Practices of Infectious Diseases (Mandell, G.L., Bennet, J.E., Dolin, R., Eds.), pp. 2070–2078. Churchill-Livingstone, New York.
  • 6
    Meyer, K.F. (1970) Effectiveness of live or killed plague vaccines in man. Bull. WHO 42, 653666.
  • 7
    Williamson, E.D., Eley, S.M., Griffin, K.F., Green, M., Russell, P., Oyston, P.C.F., Easterbrook, T., Reddin, K.M., Robinson, A. and Titball, R.W (1995) A new improved sub-unit vaccine for plague: the basis of protection. FEMS Immunol. Med. Microbiol. 12, 223230.
  • 8
    Williamson, E.D., Eley, S.M., Stagg, A.J., Green, M., Russell, P. and Titball, R.W. (1997) A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague. Vaccine 15 (10), 1079–1084.
  • 9
    Cavanaugh, D.C. and Randall, R. (1959) The role of multiplication of Pasteurella pestis in mononuclear phagocytes in the pathogenesis of flea-borne plague. J. Immunol. 83, 348363.
  • 10
    Nakajima, R., Motin, V.L. and Brubaker, R.R (1995) Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunisation. Infect. Immun. 63, 30213029.
  • 11
    Mosier, D.E., Gulizia, R.J., Baird, S.M. and Wilson, D.B. (1988) Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335, 256.
  • 12
    Leary, S.E.C., Williamson, E.D., Griffin, K., Russell, P., Eley, S.M. and Titball, R.W (1995) Active immunisation with recombinant V antigen from Yersinia pestis protects mice against plague. Infect. Immun. 63, 28542858.
  • 13
    Williamson, E.D. and Titball, R.W. (1993) A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas gangrene. Vaccine 11, 12531258.
  • 14
    Russell, P., Eley, S.M., Hibbs, S.E., Manchee, R.J., Stagg, A.J. and Titball, R.W (1995) A comparison of plague vaccine USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine 13, 15511556.
  • 15
    Wu, S.L., Hayes, C.G., Dubois, D.R., Windheuser, M.G., Kang, Y., Watts, D.M. and Seickmann, D.G (1995) Evaluation of the severe combined immunodeficient (SCID) mouse as an animal model for dengue viral infection. Am. J. Trop. Med. Hyg. 52, 468476.
  • 16
    Lindblad, E.R. (1995) In: The Theory and Practical Applications of Adjuvants (Stewart-Tull, D.E.S., Ed.), pp. 21–36. John Wiley and Sons, Chichester, UK.